|
FY2022
12 months to Dec 31, 2022
|
FY2021
8 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows Used in Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Offering costs allocated to warrant liabilities | ||
| Stock-based compensation | ||
| Unrealized change in fair value of derivative warrant liabilities | ||
| Interest income | ||
| Income earned in marketable securities held in Trust Account | ||
| Other changes | ||
| Changes in operating assets and liabilities: | ||
| Other current assets | ||
| Accounts payable and accrued expenses | ||
| Non-current assets | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Proceeds deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of costs | ||
| Proceeds from private placement | ||
| Proceeds from sale of common stock to initial shareholders | ||
| Payment of deferred offering costs | ||
| Proceeds from loans from related parties | ||
| Repayments of loans from related parties | ||
| Net cash (used in) provided by financing activities | ||
| Net increase in cash | ||
| Net (decrease) increase in cash | ||
| Cash, beginning of period | ||
| Cash, end of the period | ||
| Supplemental disclosure with respect to cash flows | ||
| Initial value of common stock subject to possible redemption | ||
| Deferred underwriter commissions payable | ||
| Initial classification of derivative warrant liabilities | ||
| Class B sponsor contribution | ||
| Change in value of Class A ordinary shares subject to possible redemption |
Loading...
